Kiniksa Pharmaceuticals International Plc (KNSA)
58.60
+1.67
(+2.93%)
USD |
NASDAQ |
May 08, 16:00
58.54
-0.06
(-0.10%)
Pre-Market: 20:00
Kiniksa Pharmaceuticals International Shareholders Equity (Quarterly) : 605.69M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 567.63M |
| Amgen, Inc. | 9.19B |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| United Therapeutics Corp. | 5.901B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 825.28M |
| Total Liabilities (Quarterly) | 219.59M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 3.794 |
| Net Debt Paydown Yield | 0.00% |